RxDoctor Payments DataLook up a doctor →

Barbara Rizzardi

Internal Medicine · Sandy, UTNPI 1245385319

Payments from drug & device makers

$27,817,897in general payments, 2019–2025

Across 5,021 payments — averaging $5540.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$8.8M
  • Emergent Biosolutions Inc.$3.2M
  • Pfizer$3M
  • AstraZeneca$2.8M
  • GSK$1.5M
  • Seqirus USA Inc$991K
  • plus $7.5M from 41 others
$253,783in research payments, 2019–2025

Across 50 payments — averaging $5075.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Valneva Austria GmbH$225K
  • Eli Lilly$22K
  • Sanofi US Services Inc.$3K
  • GSK$2K
  • Bavarian Nordic A/s$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$27,817,897 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah

Other internal medicine in Sandy

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →